Ever wondered what happens when you infect an hNTCP transgenic mouse with hepatitis delta? You can find out in Ben’s new paper, titled “Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection!” The study reveals a novel and sophisticated model to study hepatitis delta infection in vivo, linked here: 
Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection

See also the recent news release by AAAS about the study! 
Genetically humanized mice could boost fight against aggressive hepatitis

hdv_pr_movie.mp4